DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Learning Objective I

Coronary Heart Disease Risk Profile of Women with PCOS: Collision of Evidence and Assumptions Evelyn Talbott, Dr.P.H. Kim Sutton-Tyrrell, Dr.P.H. Lewis H. Kuller, M.D., Dr.P.H.…

Documents Attualità nell’impiego delle statine

Attualità nell’impiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna I^ U.L.S.S. n°…

Documents The Importance of Potential Statin in High Risk Patient

Assessment of Risk in Cardiovascular Disease The Importance of Potential Statin in High Risk Patient Masrul Syafri Bagian Kardiologi & Kedokteran Vaskular FKUA/RS M Djamil…

Documents LDL-Cholesterol – Lower is Better

Slide 1 LDL-Cholesterol – Lower is Better Reducing CHD in high risk patients 04/16 CARD-1063303-0004 Date of preparation May 2014 1 Contents Contents Slide Presentation…

Documents Chapter 07

Chapter 01 Chapter 07 Physical Activity and Dyslipidemia 1 Physical Activity and Dyslipidemia Hypercholesterolemia : is defined as levels of total serum cholesterol that…

Documents Dy Spide Miafd

Dyspidemia Dyspidemia CRE/006/FEB14-FEB15/BR 1 CVD is a leading cause of death worldwide According to the WHO,1 “An estimated 17.3 million people died from CVDs in 2008.”…

Documents VOYAGER

VOYAGER An indiVidual patient data meta-analysis Of statin therapY in At risk Groups: Effects of Rosuvastatin, atorvastatin and simvastatin  Please see slide 27 for prescribing…

Documents Learning Objective I

Coronary Heart Disease Risk Profile of Women with PCOS: Collision of Evidence and Assumptions Evelyn Talbott, Dr.P.H. Kim Sutton-Tyrrell, Dr.P.H. Lewis H. Kuller, M.D., Dr.P.H.…

Documents Autism, Depression and Alzheimer’s: A Shared Underlying Pathology and Treatment

Autism, Depression and Alzheimer’s: A Shared Underlying Pathology and Treatment Autism, Depression and Alzheimer’s: A Shared Underlying Pathology and Treatment Wise Traditions…

Documents Virginia ACP MSFM Session - Lipid Management & CVD Risk Reduction -

Slide 1 Virginia ACP MSFM Session - Lipid Management & CVD Risk Reduction - Q1. What is the evidence that adding a second pharmacologic agent to statin therapy improves…